2014/2562(DEA) | [ParlTrack]

BETA

Changes: 2021/05/04events.type, 2020/12/09events.docs.url, procedure.stage_reached, docs.docs.url, 2019/08/07committees.date, 2019/07/06events, procedure.dossier_of_the_committee, activities, committees, procedure.subject, docs, links, other, procedure.summary, 2014/07/27activities.body, 2014/04/16activities, procedure.stage_reached, 2014/03/23procedure.summary, 2014/02/11activities, procedure.dossier_of_the_committee, procedure.stage_reached

View current state | View Changes for this date

Preparatory phase in Parliament

2014/2562(DEA) Situations in which post-authorisation efficacy studies may be required

Role	Committee	Rapporteur	Shadows
Lead	ENVI

Subjects

4.20.04 Pharmaceutical products and industry

Links

Activites

2014/02/03 Initial period for examining delegated act 2 month(s)
2014/02/03 Non-legislative basic document published
- C(2014)00432

Documents

Non-legislative basic document published: C(2014)00432

History

(these mark the time of scraping, not the official date of the change)

2014-02-11Show (3) Changes | Timetravel

activities/2	date 2014-02-05T00:00:00 body EP type Committee referral announced in Parliament, 1st reading/single reading committees body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
procedure/dossier_of_the_committee	ENVI/7/15178
procedure/stage_reached	Old Preparatory phase in Parliament New Awaiting committee decision

2014-02-07Show (5) Changes

activities	date: 2014-02-03T00:00:00 body: unknown type: Initial period for examining delegated act 2 month(s) date: 2014-02-03T00:00:00 docs: type: Non-legislative basic document published title: C(2014)00432 type: Non-legislative basic document published body: EC commission:
committees	body: EP responsible: True committee_full: Environment, Public Health and Food Safety committee: ENVI
links
other
procedure	reference 2014/2562(DEA) title Situations in which post-authorisation efficacy studies may be required stage_reached Preparatory phase in Parliament subtype Examination of delegated act type DEA - Delegated acts procedure subject 4.20.04 Pharmaceutical products and industry